People

Dan Donovan specializes in congressional, state attorneys general and parallel government investigations. A former Chief Investigative Counsel in the Senate, Dan is a partner in our Government Advocacy and Congressional Investigations practices perennially recognized by Chambers USA: “King & Spalding is best known for its impressive congressional investigations practice, with several dedicated members working exclusively in this area." Dan has two decades of crisis management experience with government investigations, involving significant legal, public relations and political risks.

Dan represents leading companies, individuals, trade associations, and nonprofit entities and provides effective crisis management counsel. He works at the forefront of controversial and politicized national and state policy issues that frequently lead to investigations and litigation, including congressional, multi-state and federal agency enforcement actions. Particularly experienced in anticipating and responding to congressional committee requests and subpoenas, Dan prepares clients for high-profile hearings and guides them through the unique challenges presented by congressional and parallel government investigations.

Before joining the firm, Dan served as Chief Investigative Counsel to Senator Charles Grassley, then Chairman of Committee on Finance (and current Chairman of the Judiciary Committee). While serving in the U.S. Senate, Dan managed congressional investigations and oversight hearings. In this role, Dan directed investigations focused on statutory and regulatory compliance, including drug and device safety, drug pricing, and waste, fraud and abuse in Medicare, Medicaid and other government programs. He also handled policy and legislative matters, including the False Claims Act, the Food, Drug, and Cosmetic Act, Medicare and Medicaid programs, and related statutes. Dan also served as Chief Investigative Counsel to the Senate Committee on Small Business, where he managed consumer fraud and small business protection investigations and hearings. He began his congressional career as a Staff Assistant on the Senate Committee on Governmental Affairs, chaired by Senator Fred Thompson, working on the special investigation into the 1996 federal election campaigns.

Dan also provides strategic policy and legislative counsel, and is a frequent speaker on congressional oversight and investigations.

Full Bio

Credentials

B.A., University of Rochester

J.D., American University

District of Columbia

Maryland

Matters

Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the healthcare, pharmaceutical, medical device, accounting, defense, energy, food, and insurance industries.

Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.

Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations.

See more
Icon close

Close

Matters

Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the healthcare, pharmaceutical, medical device, accounting, defense, energy, food, and insurance industries.

Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.

Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations.

Representing Pfizer Inc. in connection with congressional investigations.

Representing Toyota in investigations and hearings by the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, and the Senate Commerce, Science and Transportation Committee relating to allegations of unintended acceleration and recalls of certain vehicles with Takata air bag inflators.

Representing a variety of clients on healthcare policy and legislative issues.

Represented a major university and pharmaceutical company in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research.

Represented a global financial institution in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters.

Represented a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds.

Represented multiple pharmaceutical companies in House and Senate investigations related to Affordable Care Act enactment and implementation.

Represented medical device companies in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians.

Represented a leading clean energy technology company in connection with a Senate investigation into Department of Energy grant program.

Represented a major oil company in connection with congressional investigations.

Represented a health insurer in House and Senate investigations related to Affordable Care Act implementation.

Represented a coalition of food product companies in connection with congressional inquiries relating to food safety and regulatory issues.

Represented a medical society in connection with Senate committee investigations in payments to physicians.

Represented individuals in connection with House and Senate committee inquiries and ethics investigations.

Matters

Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the healthcare, pharmaceutical, medical device, accounting, defense, energy, food, and insurance industries.

Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.

Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations.

See more
Icon close

Close

Matters

Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the healthcare, pharmaceutical, medical device, accounting, defense, energy, food, and insurance industries.

Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.

Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations.

Representing Pfizer Inc. in connection with congressional investigations.

Representing Toyota in investigations and hearings by the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, and the Senate Commerce, Science and Transportation Committee relating to allegations of unintended acceleration and recalls of certain vehicles with Takata air bag inflators.

Representing a variety of clients on healthcare policy and legislative issues.

Represented a major university and pharmaceutical company in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research.

Represented a global financial institution in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters.

Represented a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds.

Represented multiple pharmaceutical companies in House and Senate investigations related to Affordable Care Act enactment and implementation.

Represented medical device companies in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians.

Represented a leading clean energy technology company in connection with a Senate investigation into Department of Energy grant program.

Represented a major oil company in connection with congressional investigations.

Represented a health insurer in House and Senate investigations related to Affordable Care Act implementation.

Represented a coalition of food product companies in connection with congressional inquiries relating to food safety and regulatory issues.

Represented a medical society in connection with Senate committee investigations in payments to physicians.

Represented individuals in connection with House and Senate committee inquiries and ethics investigations.

Credentials

B.A., University of Rochester

J.D., American University

District of Columbia

Maryland